The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 16, 2020

Filed:

May. 22, 2018
Applicant:

National Institute of Biological Sciences, Beijing, Beijing, CN;

Inventors:

Zhiyuan Zhang, Beijing, CN;

Xiaodong Wang, Beijing, CN;

Xiaoguang Lei, Beijing, CN;

Yaning Su, Beijing, CN;

Sudan He, Beijing, CN;

Hanying Ruan, Beijing, CN;

Liming Sun, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 255/60 (2006.01); C07C 275/24 (2006.01); C07C 311/14 (2006.01); C07C 313/06 (2006.01); C07D 231/12 (2006.01); C07D 217/14 (2006.01); C07D 333/20 (2006.01); C07D 277/28 (2006.01); C07D 211/28 (2006.01); C07D 213/40 (2006.01); C07D 213/61 (2006.01); C07D 213/64 (2006.01); C07D 307/14 (2006.01); C07D 307/52 (2006.01); C07C 233/05 (2006.01); C07C 233/13 (2006.01); C07C 233/18 (2006.01); C07C 233/47 (2006.01); C07C 233/59 (2006.01); C07C 233/01 (2006.01); C07C 235/10 (2006.01); C07C 237/06 (2006.01); C07C 237/22 (2006.01); C07C 25/02 (2006.01); C07C 25/13 (2006.01); C07C 259/06 (2006.01); A61K 31/10 (2006.01); A61K 31/165 (2006.01);
U.S. Cl.
CPC ...
A61K 31/165 (2013.01); A61K 31/10 (2013.01); C07C 25/02 (2013.01); C07C 25/13 (2013.01); C07C 233/01 (2013.01); C07C 233/05 (2013.01); C07C 233/13 (2013.01); C07C 233/18 (2013.01); C07C 233/47 (2013.01); C07C 233/59 (2013.01); C07C 235/10 (2013.01); C07C 237/06 (2013.01); C07C 237/22 (2013.01); C07C 255/60 (2013.01); C07C 259/06 (2013.01); C07C 275/24 (2013.01); C07C 311/14 (2013.01); C07C 313/06 (2013.01); C07D 211/28 (2013.01); C07D 213/40 (2013.01); C07D 213/61 (2013.01); C07D 213/64 (2013.01); C07D 217/14 (2013.01); C07D 231/12 (2013.01); C07D 277/28 (2013.01); C07D 307/14 (2013.01); C07D 307/52 (2013.01); C07D 333/20 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/08 (2017.05); C07C 2601/10 (2017.05); C07C 2601/14 (2017.05); C07C 2603/74 (2017.05);
Abstract

The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.


Find Patent Forward Citations

Loading…